| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 577,716 | 828,927 | 960,378 | 1,210,757 | | Cost of Revenue | 439,129 | 710,092 | 808,252 | 1,031,325 | | | Gross Profit | 138,587 | 118,835 | 152,126 | 179,432 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 77,388 | 142,315 | 138,996 | 156,780 | | Non Recurring | 14,415 | 54,915 | 14,744 | 56,370 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 46,784 | (78,395) | (1,614) | (33,718) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,261) | (24) | 7,858 | 2,354 | | Earnings Before Interest And Taxes | 43,523 | (78,419) | 6,244 | (31,364) | | Interest Expense | 10,223 | 8,491 | 8,474 | 11,169 | | Income Before Tax | 33,300 | (86,910) | (2,230) | (42,533) | | Income Tax Expense | 23,092 | (23,040) | 2,848 | (6,382) | | Minority Interest | (424) | (647) | 5,948 |
-
| | | | Net Income From Continuing Ops | 4,907 | (64,517) | 870 | (36,151) | | | Non-recurring Events | | Discontinued Operations | (59,912) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (50,128) | (64,517) | 870 | (36,151) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($50,128) | ($64,517) | $870 | ($36,151) |
|
0.02% Nasdaq 
Income Statement
